» Articles » PMID: 12052305

Phenotype of CF and the Effects of Possible Modifier Genes

Overview
Date 2002 Jun 8
PMID 12052305
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis is an inherited multi-system disease, characterised by progressive lung disease and pancreatic insufficiency that is classically attributed to the dysfunction of a single gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR). The widely diverse phenotypic expression of CF is likely influenced by other genetic traits separate from the CFTR locus or modifier genes. Many of the genes currently under study as potential modifiers of CF, particularly those which influence the severity of lung disease, are involved in the control of infection, immunity and inflammation. Some of these include HLA class II antigens, mannose-binding lectin, alpha(1)-antitrypsin and alpha(1)-antichymotrypsin, glutathione-S-transferase, nitric oxide synthase type I, TNF-alpha, TGF-beta, IL-1beta and IL-1Ra.

Citing Articles

IL1B gene variants, but not TNF, CXCL8, IL6 and IL10, modify the course of cystic fibrosis in Polish patients.

Zakerska-Banaszak O, Gozdzik-Spychalska J, Gabryel M, Zuraszek J, Skrzypczak-Zielinska M, Slomski R F1000Res. 2024; 11:379.

PMID: 39185143 PMC: 11344199. DOI: 10.12688/f1000research.110472.3.


Mucosal Immunity in Cystic Fibrosis.

Bojanowski C, Lu S, Kolls J J Immunol. 2022; 207(12):2901-2912.

PMID: 35802761 PMC: 9270582. DOI: 10.4049/jimmunol.2100424.


TNF-alpha polymorphisms as a potential modifier gene in the cystic fibrosis.

Coutinho C, Marson F, Marcelino A, Bonadia L, Carlin M, Ribeiro A Int J Mol Epidemiol Genet. 2014; 5(2):87-99.

PMID: 24959313 PMC: 4065397.


Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease.

Reynolds W, Sermet-Gaudelus I, Gausson V, Feuillet M, Bonnefont J, Lenoir G Mediators Inflamm. 2006; 2006(2):36735.

PMID: 16883063 PMC: 1592586. DOI: 10.1155/MI/2006/36735.


Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum.

Schrijver I, Ramalingam S, Sankaran R, Swanson S, Dunlop C, Keiles S J Mol Diagn. 2005; 7(2):289-99.

PMID: 15858154 PMC: 1867528. DOI: 10.1016/S1525-1578(10)60557-0.